Français Japonais Chinois Allemand Néerlandais Espagnol Portugais

    News

    Medical excellence in Hauts-de-France—the Facing Faces Institute

    The Facing Faces Institute (IFF) was founded in 2009 by Dr. Bernard Devauchelle, head of maxillofacial surgery at Amiens University Hospital Center and known for performing the world's first partial face...

    Health start-up Japet offers relief from back pain

    Antoine Noël and Damien Bratic—both graduates of the Centrale Lille school of engineering—founded Japet Medical Devices to develop a revolutionary new solution for back pain.

    All news

    Major innovation in fight against pleural cancer

    05 Apr 2016 | Health Nutrition, A region on the move

    Lille hospital plays a key role in new treatment for pleural cancer.

    Healthcare innovation in Northern France

    For over 10 years, medicine had made no progress in treating cancer of the pleura, the membrane lining the lungs.

    But now the Bio-MAPS program, launched by Dr. Gérard Zalcman in close cooperation with 70 French hospital groups, has shown that Bevacizumab is effective in treating pleural cancer, significantly reducing mortality risk in 23% of patients who were treated with it.

    Dr. Arnaud Scherpereel, head of pulmonology and thoracic oncology at Lille University Hospital Center (CHRU) and coordinator of the Bevacizumab project, stresses that the treatment is equally effective in all patient sub-groups, including those with the worst prognosis factors.

    As a result, this new treatment solution is becoming the first-line therapy for patients with pleural cancer.

    Back to news